ATH 0.00% 0.3¢ alterity therapeutics limited

PBT2 further development!, page-8

  1. 79 Posts.
    lightbulb Created with Sketch. 10
    And from the ATHE 30/6/2020 annual report filing page 2

    "...as we expand our research and development and pre-clinical activities and commence clinical trials of our product candidates that includes ATH434 for Parkinsonian diseases, prospectively PBT2 for alternative indications and the development of other compounds"
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $8.021K 2.111M

Buyers (Bids)

No. Vol. Price($)
40 23398919 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 132896552 36
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.